Literature DB >> 10213623

Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides.

I Huq1, Y H Ping, N Tamilarasu, T M Rana.   

Abstract

Small unnatural peptides that target specific RNA structures have the potential to control biological processes. RNA-protein interactions are important in many cellular functions, including transcription, RNA splicing, and translation. One example of such interactions is the mechanism of trans-activation of human immunodeficiency virus type 1 (HIV-1) gene expression that requires the interaction of Tat protein with the trans-activation responsive region (TAR) RNA, a 59-base stem-loop structure located at the 5'-end of all nascent HIV-1 transcripts. We report here a synthetic peptide derived from Tat sequence (37-72), containing all D-amino acids, that binds in the major groove of TAR RNA and interferes with transcriptional activation by Tat protein in vitro and in HeLa cells. Our results indicate that unnatural peptides can inhibit the transcription of specific genes regulated by RNA-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10213623     DOI: 10.1021/bi982638h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA.

Authors:  Alexander Litovchick; Robert R Rando
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

2.  Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative.

Authors:  Sara Richter; Cristina Parolin; Barbara Gatto; Claudia Del Vecchio; Egidio Brocca-Cofano; Arnaldo Fravolini; Giorgio Palù; Manlio Palumbo
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Interactions of protein side chains with RNA defined with REDOR solid state NMR.

Authors:  Wei Huang; Gabriele Varani; Gary P Drobny
Journal:  J Biomol NMR       Date:  2011-09-25       Impact factor: 2.835

4.  Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.

Authors:  Amy Davidson; Thomas C Leeper; Zafiria Athanassiou; Krystyna Patora-Komisarska; Jonathan Karn; John A Robinson; Gabriele Varani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-07       Impact factor: 11.205

5.  Inhibition of gene expression in human cells through small molecule-RNA interactions.

Authors:  S Hwang; N Tamilarasu; K Ryan; I Huq; S Richter; W C Still; T M Rana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.

Authors:  Matthew S Lalonde; Michael A Lobritz; Annette Ratcliff; Mastooreh Chamanian; Zafiria Athanassiou; Mudit Tyagi; Julian Wong; John A Robinson; Jonathan Karn; Gabriele Varani; Eric J Arts
Journal:  PLoS Pathog       Date:  2011-05-19       Impact factor: 6.823

Review 7.  Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.

Authors:  Sara Trabulo; Ana Luísa Cardoso; Miguel Mano; Maria C Pedroso De Lima
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

8.  Iron(II) supramolecular helicates interfere with the HIV-1 Tat-TAR RNA interaction critical for viral replication.

Authors:  Jaroslav Malina; Michael J Hannon; Viktor Brabec
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.